Inhibition of both autophagy and RelB rescued the effects of baicalin, suggesting that this natural compound might be a potential immune therapeutic candidate for cancer therapy, with particular regard to HCC (Fig. 3)95. This evidence concerns the gene RELB and hepatocellular carcinoma.